Genetic Validation for New LDL Cholesterol-Lowering Target Genetic Validation for New LDL Cholesterol-Lowering Target
ATP citrate lyase inhibitors such as bempedoic acid lower LDL cholesterol by the same mechanism of action as statins and may provide similar or perhaps additive cardiovascular protection.Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Cardiology News Source Type: news
More News: Brain | Cardiology | Cardiovascular | Cholesterol | Genetics | Heart | Neurology | Neurosurgery | Statin Therapy